All lobbying filings

Venn Strategies

Venn Strategies filed a Q3 report for UCB, Inc. on October 20, 2026, reporting $80,000 in lobbying income.

Lobbying for UCB, Inc. · Biopharmaceutical company dealing in severe diseases in immunology and neurology.

As filed: VENN STRATEGIES for UCB, INC.

All filings by Venn Strategies · Everything UCB, Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

Georgia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Policies related to biopharmaceutical access and innovation.

Taxation/Internal Revenue Code

International tax issues and the corporate rate

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.